{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:39:00Z","timestamp":1771663140934,"version":"3.50.1"},"reference-count":52,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: COVID-19 is a multisystemic disease, primarily affecting the respiratory system. Liver involvement is frequent, but the impact on the clinical course and outcomes are controversial.  Objective: The aim was to assess liver function at the admission and evaluate its effects on severity and mortality in hospitalized patients with COVID-19.  Methods: This is a retrospective study of hospitalized patients in a tertiary hospital in Brazil, with a PCR-confirmed SARS-CoV-2 infection between April and October 2020. 1080 out of 1229 patients had liver enzymes on admission and were divided in two cohorts, based on the presence or absence of abnormal liver enzymes (ALE). Demographic, clinical, laboratory, imaging, clinical severity, and mortality were evaluated. Patients were followed until discharge, death or transfer to another institution.  Results: Median age was 60 years and 51.5% were male. The more frequent comorbidities were hypertension (51.2%), and diabetes (31.6%). Chronic liver disease and cirrhosis were present in 8.6% and 2.3%, respectively. ALE (aminotransferases higher than 40 IU\/L) were present in 56.9% of patients [mild (1-2 times): 63.9%; moderate (2-5 times): 29.8%; severe (&gt;5 times): 6.3%]. Male gender [RR 1.49, P=0.007], increased total bilirubin [RR 1.18, P&lt;0.001] and chronic liver disease [RR 1.47, P=0.015] were predictors of abnormal aminotransferases on admission. Patients with ALE had a higher risk of disease severity [RR 1.19; P=0.004]. There was no association among ALE and mortality.  Conclusion: ALE is common in COVID-19 hospitalized patients and were independently correlated with severe COVID-19. Even mild ALE at admission may be a severity prognostic marker.<\/jats:p>","DOI":"10.1590\/s0004-2803.202301000-03","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:00:00Z","timestamp":1683896400000},"page":"11-20","source":"Crossref","is-referenced-by-count":2,"title":["MINIMAL LIVER ENZYMES ABNORMALITIES AT ADMISSION ARE RELATED TO SEVERE COVID-19 CLINICAL COURSE IN A LARGE BRAZILIAN COHORT"],"prefix":"10.1590","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-5863","authenticated-orcid":false,"given":"Ysela","family":"PICON","sequence":"first","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Organiza\u00e7\u00e3o Mundial de Gastroenterologia,  Brasil; Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-0235","authenticated-orcid":false,"given":"Dvora","family":"JOVELEVITHS","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5001-246X","authenticated-orcid":false,"given":"Mario Reis","family":"ALVARES-DA-SILVA","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Organiza\u00e7\u00e3o Mundial de Gastroenterologia,  Brasil; Universidade Federal do Rio Grande do Sul,  Brasil; CNPq,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023,1]]},"reference":[{"key":"ref1","series-title":"WHO Coronavirus (COVID-19) Dashboard","year":"2022"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3201\/eid2609.202095","article-title":"Pathology and pathogenesis of SARS-CoV-2 associated with fatal coronavirus disease, United States","volume":"26","author":"Martines RB","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/jcm10030446","article-title":"Multiorgan involvement in covid-19: Beyond pulmonary manifestations","volume":"10","author":"Thakur V","year":"2021","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang C","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","first-page":"1","article-title":"The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis","author":"Harapan H","year":"2021","journal-title":"Rev Med Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"100298","DOI":"10.1016\/j.aohep.2020.100298","article-title":"Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission","volume":"21","author":"Mendizabal M","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","article-title":"COVID-19: Abnormal liver function tests","volume":"73","author":"Cai Q","year":"2020","journal-title":"J Hepatol Elsevier BV"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.aohep.2020.08.068","article-title":"The effect of liver test abnormalities on the prognosis of COVID-19","volume":"19","author":"Medetalibeyoglu A","year":"2020","journal-title":"Ann Hepatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.31404","article-title":"Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort","volume":"72","author":"Phipps MM","year":"2020","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/s41575-021-00426-4","article-title":"COVID-19 and liver disease: mechanistic and clinical perspectives","volume":"18","author":"Marjot T","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1038\/s41379-020-00649-x","article-title":"Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data","volume":"33","author":"Lagana SM","year":"2020","journal-title":"Mod Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0041-1730750","article-title":"Evaluation of liver histopathological findings of COVID-19 by minimally invasive autopsies","volume":"13","author":"Vishwajeet V","year":"2021","journal-title":"J Lab Physicians"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"100273","DOI":"10.1016\/j.aohep.2020.10.001","article-title":"Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis","volume":"21","author":"Sharma A","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","journal-title":"The Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jmv.25783","article-title":"Clinical features and treatment of COVID-19 patients in northeast Chongqing","volume":"92","author":"Wan S","year":"2020","journal-title":"J Med Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","journal-title":"The Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gutjnl-2020-321726","article-title":"Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19","volume":"70","author":"Yip TCF","year":"2021","journal-title":"Gut"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin SK","year":"2016","journal-title":"Hepatol Int"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.31404","article-title":"Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large U.S. Cohort","volume":"72","author":"Phipps MM","year":"2020","journal-title":"Hepatology"},{"key":"ref20","series-title":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health","year":"2020"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2013.243","article-title":"Comments on \u201cKDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"84","author":"Andrassy KM","year":"2013","journal-title":"Kidney Int"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","article-title":"Liver injury in COVID-19: management and challenges","volume":"5","author":"Zhang C","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref23","first-page":"1","article-title":"The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta - analysis","author":"Harapan H","year":"2021","journal-title":"Rev Med Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.31446","article-title":"Clinical Features of Patients Infected With Coronavirus Disease 2019 With Elevated Liver Biochemistries: A Multicenter, Retrospective Study","volume":"73","author":"Fu Y","year":"2021","journal-title":"Hepatology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.14309\/ajg.0000000000000717","article-title":"Liver Enzyme Elevation in Coronavirus Disease 2019","author":"Hao S-R","year":"2020","journal-title":"American Journal of Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1136\/gutjnl-2020-321726","article-title":"Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19","volume":"70","author":"Yip TCF","year":"2021","journal-title":"Gut"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"Yang X","year":"2020","journal-title":"Lancet Respir Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen N","year":"2020","journal-title":"The Lancet"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCG.0000000000001459","article-title":"WGO Guidance for the Care of Patients with COVID-19 and Liver Disease","volume":"55","author":"Hamid S","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"100391","DOI":"10.1016\/j.aohep.2021.100391","article-title":"P-27 Alteration in Liver Function Tests Among Patients Hospitalized for Covid-19: a Multicentric Study in Peru","volume":"24","author":"Mar\u00edn Due\u00f1as I","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/liv.14565","article-title":"Abnormal liver function tests predict transfer to intensive care unit and death in COVID-19","volume":"40","author":"Piano S","year":"2020","journal-title":"Liver Int"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.31472","article-title":"Elevated Liver Biochemistries in Hospitalized Chinese Patients With Severe COVID-19: Systematic Review and Meta-analysis","volume":"73","author":"Kovalic AJ","year":"2021","journal-title":"Hepatology"},{"key":"ref33","first-page":"369","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study","author":"Petrilli CM","year":"2020","journal-title":"BMJ"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12072-021-10141-6","article-title":"Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil","volume":"15","author":"Pozzobon FM","year":"2021","journal-title":"Hepatol Int"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1622533","DOI":"10.1155\/2021\/1622533","article-title":"Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America","volume":"2021","author":"Balderramo D","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle DM","year":"2020","journal-title":"Nat Med"},{"key":"ref37","first-page":"1","article-title":"D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: A case control study","volume":"8","year":"2020","journal-title":"J Intensive Care"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11239-020-02226-0","article-title":"High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?","volume":"51","author":"Iba\u00f1ez C","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"ref39","first-page":"1","article-title":"The prevalence, predictors and outcomes of acute liver injury among patients with COVID-19: A systematic review and meta-analysis","author":"Harapan H","year":"2021","journal-title":"Rev Med Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s11357-020-00232-x","article-title":"New view on older adults with COVID-19: comments on \u201cSARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes","volume":"42","author":"Xu G","year":"2020","journal-title":"Geroscience"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajem.2020.12.076","article-title":"Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis","volume":"41","author":"Hariyanto TI","year":"2021","journal-title":"American Journal of Emergency Medicine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.15916","article-title":"Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19","volume":"52","author":"Kulkarni AV","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.14309\/ajg.0000000000000717","article-title":"Liver Enzyme Elevation in Coronavirus Disease 2019","author":"Hao S-R","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"100273","DOI":"10.1016\/j.aohep.2020.10.001","article-title":"Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis","volume":"21","author":"Sharma A","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"76","DOI":"10.11606\/s1518-8787.2021055003684","article-title":"Baseline factors associated with death in a COVID-19 hospital cohort, Sao Paulo, 2020","volume":"55","author":"Konstantyner TCRO","year":"2021","journal-title":"Rev Saude Publica"},{"key":"ref46","article-title":"Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study","volume":"19","author":"Kim D","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2020.09.024","article-title":"Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study","volume":"74","author":"Marjot T","year":"2021","journal-title":"J Hepatol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2020.04.002","article-title":"Clinical Features of COVID-19-Related Liver Functional Abnormality","volume":"18","author":"Fan Z","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref49","first-page":"1","article-title":"Epidemiologic Characteristics of and Prognostic Factors for COVID-19 Among Hospitalized Patients: Updated Implications From Hubei Province, China","volume":"9","author":"Liu X","year":"2021","journal-title":"Front Public Health"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jinf.2020.03.019","article-title":"Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up","volume":"80","author":"Wang L","year":"2020","journal-title":"J Infect"},{"key":"ref51","first-page":"934","article-title":"Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu C","year":"2020","journal-title":"JAMA"},{"key":"ref52","article-title":"COVID-19 cytokine storm: the interplay between inflammation and coagulation","author":"Jose RJ","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["Altera\u00e7\u00f5es m\u00ednimas em enzimas hep\u00e1ticas \u00e0 admiss\u00e3o hospitalar correlacionam-se \u00e0 gravidade da COVID-19 em uma grande coorte no Brasil"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032023000100011&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T13:00:49Z","timestamp":1683896449000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032023000100011&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["S0004-28032023000100011"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.202301000-03","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}